Cellebrite DI (CLBT)
Official siteTECHNOLOGY • SOFTWARE - INFRASTRUCTURE • NASDAQ
Market Cap: $2.90B
Last updated: Nov 17, 2026 at 4:31 PM ET
Cellebrite DI (CLBT) Stock Chart
Cellebrite DI (CLBT) has a latest price of $10.65 on Nov 17, 2026, 45.1% below its 52-week high of $19.39. Its price fell 42.3% over the past 12 months. The month-end price rose 8.8% over the 5 years through Oct 2026, a compound annual rate of 1.7%.
Price Chart
From Aug 2021 to Oct 2026, its highest month-end close was $24.04 in Jan 2025 and its lowest $3.92 in Sep 2022, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart CLBT with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CLBT.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 5.2%, and over 6 months it fell 20.9%. The month-end price rose 81.9% over the 3 years through Oct 2026, a compound annual rate of 22.1%.
| Period | Change |
|---|---|
| 1 month | -4.4% |
| 3 months | -5.2% |
| 6 months | -20.9% |
| 12 months | -42.3% |
| 12 months, with dividends | -42.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +81.9% | +22.1% |
| 5 years | +8.8% | +1.7% |
Price by Year
Its best calendar year was 2024, when the price rose 154.4%, and its weakest was 2022, when it fell 45.6%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $12.15 | -32.6% |
| 2025 | $18.03 | -18.2% |
| 2024 | $22.03 | +154.4% |
| 2023 | $8.66 | +98.6% |
| 2022 | $4.36 | -45.6% |
Trading Range
The price is 8.0% below its 50-day average of $11.58 and 19.1% below its 200-day average of $13.16.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $10.65 | |
| 52-week high | $19.39 | -45.1% |
| 52-week low | $9.58 | +11.2% |
| 50-day average | $11.58 | -8.0% |
| 200-day average | $13.16 | -19.1% |
Price Risk
Over 3 years, its largest fall from a peak was 59.9%.
| Measure | Value |
|---|---|
| 1-year beta | 0.71 |
| Largest fall, 1 year | -45.7% |
| Largest fall, 3 years | -59.9% |
Valuation
Cellebrite DI traded at 36.1x earnings at the end of 2025, against a 5-year median of 31.2x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About CLBT
What is CLBT's 1-year price change?
Cellebrite DI's price fell 42.3% over the past 12 months. With dividends included, the 12-month total return was -42.3%.
What is CLBT's 5-year price change?
Cellebrite DI's month-end price rose 8.8% over the 5 years through Oct 2026, a compound annual rate of 1.7%. These figures leave out dividends.
What is CLBT's 52-week high and low?
Cellebrite DI's 52-week high is $19.39 and its 52-week low is $9.58. Its latest price of $10.65 on Nov 17, 2026 is 45.1% below the high.
What is CLBT's beta?
Cellebrite DI's 1-year beta against the S&P 500 is 0.71, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 45.7%.
Is the CLBT chart free?
Yes. Advanced Charting for CLBT is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
CLBT pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts